Original language | English |
---|---|
Patent number | US Patent App. 16/685,100 |
Publication status | Published - 2021 |
Stroma-targeting treatment for patients with elevated adam12 levels
Maarten F. Bijlsma (Inventor), Hanneke W. M. van Laarhoven (Inventor)
Research output: Patent › Professional